SignalRx launches Salesforce-native revenue intelligence for HealthTech

SignalRx has launched a HealthTech-only revenue intelligence platform inside Salesforce to help revenue teams spot accounts likely to expand and prospects likely to convert. The company says the tool is live now, typically deploys in 30 days and aims to improve net revenue retention by focusing teams on the highest-value opportunities.

Why it matters: - HealthTech sales teams often manage layered buying groups across pharmacies, practices, networks and MSOs, which makes growth harder to predict. - SignalRx is built to help teams focus on the accounts and prospects most likely to drive net revenue retention. - The platform is native to Salesforce, which means teams can use the insights without switching tools.

What happened: - SignalRx launched a revenue intelligence platform built exclusively for HealthTech companies. - The platform identifies customers most likely to expand and prospects most likely to convert. - SignalRx writes those insights directly into Salesforce. - The company says the product is available now and is typically live within 30 days. - HealthTech revenue leaders can request 10 net-new accounts scored against their best customers, delivered as a live dashboard within 24 hours, with no sales call required.

The details: - The platform scores every account and contact for future value. - It surfaces expansion and wallet-share opportunities within existing customers. - It identifies high-fit prospects that resemble customers who buy, stay and grow. - Each account includes a fit score, customer segment and recommended revenue play in an Intelligence Card inside Salesforce. - Only administrators log into SignalRx. - Sales, customer success and marketing teams keep working inside Salesforce. - SignalRx was developed after years of work alongside HealthTech revenue leaders through the GoodWork platform. - The company says the platform models a company’s customers, revenue and healthcare-specific signals that determine who buys next. - SignalRx says the platform is built to prioritize accounts and contacts that drive NRR.

Between the lines: - HealthTech vendors are facing higher customer acquisition costs, so expansion inside the existing base matters more. - SignalRx is positioning itself against horizontal sales tools that were built for simpler account structures. - The pitch is less about adding more data and more about turning data into clear next steps for revenue teams. - PatientNow’s chief revenue officer Bridget Winston said the platform changed how the company identifies and prioritizes growth, and that teams now align around a shared understanding of the customer.

What's next: - SignalRx is asking HealthTech revenue leaders to start with a 10-account scoring test. - The company says the dashboard can be delivered within 24 hours. - SignalRx will likely use early deployments to show whether its scoring and play recommendations translate into better expansion and conversion outcomes.

The bottom line: - SignalRx is betting that HealthTech teams want Salesforce-native guidance on where growth is most likely to come from, not another standalone system.